Compare Orchid Chemicals with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs ALEMBIC LTD - Comparison Results

ORCHID PHARMA LTD     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD ALEMBIC LTD ORCHID PHARMA LTD/
ALEMBIC LTD
 
P/E (TTM) x -0.5 67.8 - View Chart
P/BV x 0.1 2.4 4.9% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 ORCHID PHARMA LTD   ALEMBIC LTD
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
ALEMBIC LTD
Mar-18
ORCHID PHARMA LTD/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs19472 269.4%   
Low Rs3534 103.2%   
Sales per share (Unadj.) Rs276.54.7 5,881.5%  
Earnings per share (Unadj.) Rs-79.26.1 -1,297.7%  
Cash flow per share (Unadj.) Rs-43.56.2 -695.7%  
Dividends per share (Unadj.) Rs00.20 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs53.940.7 132.7%  
Shares outstanding (eoy) m70.45267.03 26.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.411.3 3.7%   
Avg P/E ratio x-1.48.7 -16.7%  
P/CF ratio (eoy) x-2.68.5 -31.1%  
Price / Book Value ratio x2.11.3 163.0%  
Dividend payout %03.3 0.0%   
Avg Mkt Cap Rs m8,06714,139 57.1%   
No. of employees `0002.8NA-   
Total wages/salary Rs m2,527207 1,218.4%   
Avg. sales/employee Rs Th6,956.1NM-  
Avg. wages/employee Rs Th902.5NM-  
Avg. net profit/employee Rs Th-1,993.0NM-  
INCOME DATA
Net Sales Rs m19,4771,255 1,551.7%  
Other income Rs m407370 110.0%   
Total revenues Rs m19,8841,625 1,223.3%   
Gross profit Rs m1,103111 992.4%  
Depreciation Rs m2,51938 6,664.6%   
Interest Rs m5,2272 307,458.8%   
Profit before tax Rs m-6,236442 -1,411.5%   
Minority Interest Rs m200-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-12524 -522.8%   
Profit after tax Rs m-5,5801,630 -342.4%  
Gross profit margin %5.78.9 64.0%  
Effective tax rate %2.05.4 37.0%   
Net profit margin %-28.7129.8 -22.1%  
BALANCE SHEET DATA
Current assets Rs m11,0141,867 589.9%   
Current liabilities Rs m32,060591 5,422.9%   
Net working cap to sales %-108.1101.6 -106.3%  
Current ratio x0.33.2 10.9%  
Inventory Days Days9594 100.7%  
Debtors Days Days3474 45.6%  
Net fixed assets Rs m29,4401,791 1,643.9%   
Share capital Rs m705534 131.9%   
"Free" reserves Rs m2,04310,324 19.8%   
Net worth Rs m3,80010,858 35.0%   
Long term debt Rs m9,01841 21,888.1%   
Total assets Rs m46,51011,591 401.3%  
Interest coverage x-0.2260.9 -0.1%   
Debt to equity ratio x2.40 62,542.3%  
Sales to assets ratio x0.40.1 386.7%   
Return on assets %-0.814.1 -5.4%  
Return on equity %-146.915.0 -978.3%  
Return on capital %-3.715.2 -24.6%  
Exports to sales %37.91.5 2,450.8%   
Imports to sales %22.621.0 107.8%   
Exports (fob) Rs m7,37819 38,028.9%   
Imports (cif) Rs m4,406263 1,673.2%   
Fx inflow Rs m7,51319 38,728.4%   
Fx outflow Rs m5,649264 2,141.2%   
Net fx Rs m1,865-244 -762.8%   
CASH FLOW
From Operations Rs m1,682236 713.2%  
From Investments Rs m-9,860-224 4,402.0%  
From Financial Activity Rs m6,644-27 -24,976.7%  
Net Cashflow Rs m-1,535-15 10,371.6%  

Share Holding

Indian Promoters % 32.3 64.0 50.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 0.2 2,300.0%  
FIIs % 3.3 9.7 34.0%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 26.1 211.9%  
Shareholders   84,811 54,701 155.0%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   DIVIS LABORATORIES  WOCKHARDT  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  TORRENT PHARMA  

Compare ORCHID PHARMA LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 5-YR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS